U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H23N7O
Molecular Weight 365.4322
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SLC-391

SMILES

NC1=C(C=C(C=N1)C2=CN(N=C2)C3CCNCC3)C4=NN=C(CC5CC5)O4

InChI

InChIKey=JYVSYFGHYFXYBE-UHFFFAOYSA-N
InChI=1S/C19H23N7O/c20-18-16(19-25-24-17(27-19)7-12-1-2-12)8-13(9-22-18)14-10-23-26(11-14)15-3-5-21-6-4-15/h8-12,15,21H,1-7H2,(H2,20,22)

HIDE SMILES / InChI

Molecular Formula C19H23N7O
Molecular Weight 365.4322
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 19:17:30 UTC 2023
Edited
by admin
on Sat Dec 16 19:17:30 UTC 2023
Record UNII
DSP7A26K25
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SLC-391
Code English
SLC-0211
Code English
SLC0211
Code English
SLC391
Code English
2-Pyridinamine, 3-[5-(cyclopropylmethyl)-1,3,4-oxadiazol-2-yl]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-
Systematic Name English
3-[5-(Cyclopropylmethyl)-1,3,4-oxadiazol-2-yl]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine
Systematic Name English
Code System Code Type Description
PUBCHEM
118110201
Created by admin on Sat Dec 16 19:17:31 UTC 2023 , Edited by admin on Sat Dec 16 19:17:31 UTC 2023
PRIMARY
CAS
1783825-18-2
Created by admin on Sat Dec 16 19:17:31 UTC 2023 , Edited by admin on Sat Dec 16 19:17:31 UTC 2023
PRIMARY
FDA UNII
DSP7A26K25
Created by admin on Sat Dec 16 19:17:31 UTC 2023 , Edited by admin on Sat Dec 16 19:17:31 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY